Flutiform 50/5® (fluticasone propionate + formoterol (eformoterol)) PBS pricing information
03 Apr 2023
Commencing 1 April 2023, the price of flutiform 50/5® (fluticasone propionate + formoterol (eformoterol)) as listed under item code 2827T on the Pharmaceutical Benefits Scheme (PBS) has was incorrectly reduced.
The price for 2827T that appears in the 1 April 2023 PBS Schedule is therefore incorrect. Please see the following erratum which has been published to correct the pricing of this brand in the PBS Schedule for 1 April 2023.
In addition, the ex-manufacturer prices spreadsheet for 1 April 2023 also reflects the correct prices for flutiform 50/5.
Pricing information for flutiform 50/5® as linked above supersedes any previous pricing information published on this website. The correct pricing will appear in the PBS Schedule for 1 May 2023.
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
- Medicine Shortage
Popular Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy